AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Marie McCullough
PHILADELPHIA _ Adding to conflicting research on the risks and benefits of postmenopausal estrogen therapy, a large new study concludes that taking the hormone for at least 10 years significantly raises the risk of dying from ovarian cancer.
But even with this study, the link is not proven and questions remain.
The study was launched so long ago that it focused on women who took estrogen alone, even though women today usually take estrogen with progestin _ a regimen that may reduce any ovarian cancer risk.
Meanwhile, other studies have not found a link to ovarian cancer.
In Wednesday's study, published in…